Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

Managing Coronavirus/COVID-19: Illness in the C-Suite – Disclosure and Other Considerations for Public Companies

Alert April 2, 2020

When an executive officer or director becomes seriously ill, including due to COVID-19, U.S. public companies and foreign private issuers must consider their disclosure obligations as well as governance and other key topics. This alert discusses these considerations.

View More

Share links:

Share links:

Related Professionals

Related Practices

Related Offices

Related Regions

Related News & Insights